Nelson Peltz, an activist investor and known as a large DuPont shareholder, was nominated by his Trian Fund, along with three members to the board, breaking up the industrial conglomerate. Trian Fund, Management LP, where Peltz is the head, revealed that investment funds it manage currently total to 24.3 million of shares in the DuPont company, totaling to about $1.8B or 2.68 percent.
However, Trian revealed in a statement that the company DuPont has not kept its promises or has held its management accountable for missing, repeatedly, the promised earning targets and revenue. In a statement, DuPont revealed that its current board would be looking into the nominees from Trian and would make a recommendation on what would be best for the overall interest of the shareholders.
To defend harsh remarks from Trian, DuPont revealed its competitive stock returns under the wing of its team since the last months of 2008; more so, it also noted of the revamping being done by its qualified directors. Lastly, it noted about its ongoing cost cutting measures.
Peltz pushed the company to segregate its industrial biosciences, nutrition and health and agriculture units from more volatile units with strong cash flow. On a final note, DuPont cited about it advantage in the competition due to its strong global scale, science platform, brand and market access, combined.